Empagliflozin 25 MG trials for Chronic kidney disease

All Empagliflozin 25 MG trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Empagliflozin 25 MG for Chronic kidney disease

• EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
  NCT06249945 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 2 locations
• Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
  NCT06249932 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 4 locations
• meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
  NCT05715814 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Empagliflozin 25 MG for Chronic kidney disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.